Treatment Patterns & Clinical Outcomes of Palbociclib Combinations in HR+HER2-MBC

Clinical trial NCT04937660 · COMPLETED

Trial details

NCT number: NCT04937660
Sponsor: Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

Metastatic Breast Cancer

Start date: 2021-07-15
Primary completion: 2025-04-29
Enrollment: 185

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.